Clinical Trials Browser

OTHER_GOV × Drug Therapy × Breast × Clear all

NCT04681287 2023-09-25

Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.

Phase 2 Unknown

HER2 Positive Metastatic Breast Cancer

NCT04488614 2020-07-30

PBCB

Enrolling by invitation

Breast Neoplasms, Fatigue

NCT03062072 2017-04-07

ECHO

BreastGastrointestinalLymphoid

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Neoplasms